SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-003366
Filing Date
2018-11-13
Accepted
2018-11-13 14:20:52
Documents
39
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cannapharmarx_10q-093018.htm 10-Q 196753
2 CERTIFICATION cannapharmarx_10q-ex3101.htm EX-31.1 7353
3 CERTIFICATION cannapharmarx_10q-ex3102.htm EX-31.2 7107
4 CERTIFICATION cannapharmarx_10q-ex32.htm EX-32 3837
  Complete submission text file 0001683168-18-003366.txt   1155275

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20180930.xml EX-101.INS 136438
6 XBRL SCHEMA FILE cpmd-20180930.xsd EX-101.SCH 14111
7 XBRL CALCULATION FILE cpmd-20180930_cal.xml EX-101.CAL 31428
8 XBRL DEFINITION FILE cpmd-20180930_def.xml EX-101.DEF 24087
9 XBRL LABEL FILE cpmd-20180930_lab.xml EX-101.LAB 104328
10 XBRL PRESENTATION FILE cpmd-20180930_pre.xml EX-101.PRE 84125
Mailing Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614
Business Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 181177193
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1